Encube-002

Acne Vulgaris

PreclinicalActive

Key Facts

Indication

Acne Vulgaris

Phase

Preclinical

Status

Active

Company

A private Indian biotech delivering nano‑emulsion based dermatology drugs with enhanced skin penetration.

Drug	Company	Phase	Status
Pipeline Program	MatriSys Bioscience	Preclinical	Active
AKVANO®-based Acne treatment	Lipidor	Pre-clinical/Phase 1	Active
Acne & Impure Skin	Pelpharma Handels	Commercial	Active
GM-503	Galderma Group	Phase 1	Active
CB-03-01 (Cortexolone 17α-propionate)	Cosmo Pharmaceuticals	Phase III	Regulatory Review (via Cassiopea)
TWYNEO® (tretinoin/BPO)	Sol-Gel Technologies	Commercial	Active
SGT-510	Sol-Gel Technologies	Phase 2	Active
TWYNEO®	Mayne Pharma Group	Marketed	Recently Launched (Acquired)
TVB-3567	Sagimet Biosciences	Phase 1	First-in-human trial initiated June 2025